Page 2 - பெய்ஜிங் உயிரியல் ப்ராடக்ட்ஸ் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பெய்ஜிங் உயிரியல் ப்ராடக்ட்ஸ் நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பெய்ஜிங் உயிரியல் ப்ராடக்ட்ஸ் நிறுவனம் Today - Breaking & Trending Today

WHO gives emergency approval to Sinopharm, first Chinese Covid vaccine

GENEVA: The World Health Organisation approved a Covid-19 vaccine from China’s state-owned drugmaker Sinopharm for emergency use on Friday, a boost to Beijing’s push for a big role in inoculating the world.
The vaccine, one of two main Chinese coronavirus vaccines that collectively have already been given to hundreds of millions of people in China and elsewhere, is the first developed by a non-Western country to win WHO backing. It is also the first time the WHO has given emergency use approval to a Chinese vaccine for any infectious disease.
A WHO emergency listing is a signal to national regulators that a product is safe and effective. It also allows it to be included in COVAX, a global programme to provide vaccines mainly for poor countries, which has hit supply problems. ....

United States , Tedros Adhanom Ghebreyesus , Sinovac Biotech , World Health Organisation , China National Biotec Group , Products Institute , Strategic Advisory Group Of Experts , General Tedros Adhanom Ghebreyesus , Strategic Advisory Group , Beijing Biological Products Institute , Latin America , ஒன்றுபட்டது மாநிலங்களில் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , சீனா தேசிய பயோடெக் குழு , ப்ராடக்ட்ஸ் நிறுவனம் , பெய்ஜிங் உயிரியல் ப்ராடக்ட்ஸ் நிறுவனம் , லத்தீன் அமெரிக்கா ,

WHO approves China's Sinopharm vaccine - Newspaper

GENEVA: The World Health Organisation approved a Covid-19 vaccine from China’s state-owned drugmaker Sinopharm for emergency use on Friday, a boost to Beijing’s push for a big role in inoculating the world.
The vaccine, one of two main Chinese coronavirus vaccines that collectively have already been given to hundreds of millions of people in China and elsewhere, is the first developed by a non-Western country to win WHO backing. It is also the first time the WHO has given emergency use approval to a Chinese vaccine for any infectious disease.
A WHO emergency listing is a signal to national regulators that a product is safe and effective. It also allows it to be included in COVAX, a global programme to provide vaccines mainly for poor countries, which has hit supply problems. ....

United States , Tedros Adhanom Ghebreyesus , Sinovac Biotech , World Health Organisation , China National Biotec Group , Products Institute , Strategic Advisory Group Of Experts , General Tedros Adhanom Ghebreyesus , Strategic Advisory Group , Beijing Biological Products Institute , Latin America , ஒன்றுபட்டது மாநிலங்களில் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , சீனா தேசிய பயோடெக் குழு , ப்ராடக்ட்ஸ் நிறுவனம் , பெய்ஜிங் உயிரியல் ப்ராடக்ட்ஸ் நிறுவனம் , லத்தீன் அமெரிக்கா ,

WHO emergency approval for COVID vaccine made by Chinese company

The World Health Organisation (WHO) has granted emergency approval for the coronavirus (COVID-19) vaccine made by Chinese company Sinopharm. It is the first vaccine developed by a non-Western country to get WHO backing. The vaccine has already been given to millions of people in China and elsewhere. The WHO had previously only approved the vaccines made by Pfizer, AstraZeneca, Johnson & Johnson and Moderna. But individual health regulators in various … ....

United States , Tedros Adhanom Ghebreyesus , Products Institute , World Health Organisation , Latin America , Beijing Biological Products Institute , ஒன்றுபட்டது மாநிலங்களில் , ப்ராடக்ட்ஸ் நிறுவனம் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , லத்தீன் அமெரிக்கா , பெய்ஜிங் உயிரியல் ப்ராடக்ட்ஸ் நிறுவனம் ,

WHO approves China's Sinopharm vaccine in potential boost to COVAX pipeline

WHO approves China s Sinopharm vaccine in potential boost to COVAX pipeline
Today
12:00 pm JST
Today | 12:23 pm JST
GENEVA
The World Health Organization(WHO) approved for emergency use a COVID-19 vaccine from China s state-owned drugmaker Sinopharm on Friday, bolstering Beijing s push for a bigger role in inoculating the world.
The vaccine, one of two main Chinese coronavirus vaccines that have been given to hundreds of millions of people in China and elsewhere, is the first developed by a non-Western country to win WHO backing.
It is also the first time the WHO has given emergency use approval to a Chinese vaccine for any infectious disease. Earlier this week, separate WHO experts had expressed concern about the quality of data the company provided on side effects. ....

United States , Bruce Aylward , Arnaud Didierlaurent , Tedros Adhanom Ghebreyesus , Alejandro Craviato , Sinovac Biotech , World Health Organization , China National Biotec Group , Products Institute , Strategic Advisory Group Of Experts , General Tedros Adhanom Ghebreyesus , Strategic Advisory Group , Beijing Biological Products Institute , Latin America , ஒன்றுபட்டது மாநிலங்களில் , காயங்கள் ஐலவ்ர்டு , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , சீனா தேசிய பயோடெக் குழு , ப்ராடக்ட்ஸ் நிறுவனம் , பெய்ஜிங் உயிரியல் ப்ராடக்ட்ஸ் நிறுவனம் , லத்தீன் அமெரிக்கா ,

WHO approves Sinopharm vaccine in potential boost to COVAX ...

Recommends Sinopharm for all ages above 18, in two doses
Says Sinopharm has estimated 79% overall efficacy rate (Adds Sinopharm statement in paragraph 8, updates vaccine numbers in final paragraph)
By Stephanie Nebehay
GENEVA, May 7 (Reuters) - The World Health Organization (WHO) approved for emergency use a COVID-19 vaccine from China s state-owned drugmaker Sinopharm on Friday, bolstering Beijing s push for a bigger role in inoculating the world.
The vaccine, one of two main Chinese coronavirus vaccines that have been given to hundreds of millions of people in China and elsewhere, is the first developed by a non-Western country to win WHO backing.
It is also the first time the WHO has given emergency use approval to a Chinese vaccine for any infectious disease. Earlier this week, separate WHO experts had expressed concern about the quality of data the company provided on side effects. ....

United States , Philippa Fletcher , Bruce Aylward , Alex Richardson Shri Navaratnam , Arnaud Didierlaurent , Tedros Adhanom Ghebreyesus , Emma Farge , Alejandro Craviato , Andrew Galbraith , Peter Graff , Roxanne Liu , Stephanie Nebehay , Kevin Liffey , Sinovac Biotech , World Health Organization , China National Biotec Group , Products Institute , Strategic Advisory Group Of Experts , Recommends Sinopharm , Says Sinopharm , Adds Sinopharm , General Tedros Adhanom Ghebreyesus , Strategic Advisory Group , Beijing Biological Products Institute , Latin America , Alex Richardson ,